Baker Bros Advisors LP Increased Acceleron Pharma (XLRN) Stake By $5.00 Million; Airboss of America Corp. (TSE:BOS) Had 1 Bullish Analysts

February 22, 2018 - By Ellis Scott

Baker Bros Advisors Lp increased Acceleron Pharma Inc. (XLRN) stake by 469.79% reported in 2017Q3 SEC filing. Baker Bros Advisors Lp acquired 135,135 shares as Acceleron Pharma Inc. (XLRN)’s stock declined 4.63%. The Baker Bros Advisors Lp holds 163,900 shares with $6.12M value, up from 28,765 last quarter. Acceleron Pharma Inc. now has $1.92 billion valuation. The stock increased 0.94% or $0.4 during the last trading session, reaching $42.4. About 191,668 shares traded. Acceleron Pharma Inc. (NASDAQ:XLRN) has declined 22.43% since February 22, 2017 and is downtrending. It has underperformed by 39.13% the S&P500.

Among 3 analysts covering Airboss Of America Corp. (TSE:BOS), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Airboss Of America Corp. had 10 analyst reports since August 13, 2015 according to SRatingsIntel. IBC maintained Airboss of America Corp. (TSE:BOS) rating on Tuesday, October 17. IBC has “Neutral” rating and $13 target. The rating was maintained by TD Securities on Friday, March 3 with “Buy”. The rating was maintained by TD Securities with “Buy” on Thursday, August 13. See Airboss of America Corp. (TSE:BOS) latest ratings:

10/11/2017 Broker: TD Securities Rating: Hold Old Target: $14.00 New Target: $13.50 Target Down
17/10/2017 Broker: IBC Rating: Neutral New Target: $13.00 Maintain

The stock decreased 0.40% or $0.04 during the last trading session, reaching $10.06. About 2,575 shares traded. Airboss of America Corp. (TSE:BOS) has 0.00% since February 22, 2017 and is . It has underperformed by 16.70% the S&P500.

AirBoss of America Corp., through its subsidiaries, develops, makes, and sells rubber products to the resource, military, automotive, and industrial markets primarily in Canada and the United States. The company has market cap of $232.25 million. The firm operates in three divisions: Rubber Compounding, Engineered Products, and Automotive. It has a 22.86 P/E ratio. The Rubber Compounding segment is involved in custom rubber compounding and supplying mixed rubber for use in mining, transportation, industrial rubber, military, automotive, conveyor belting, and other products; and distributes chemicals.

Among 16 analysts covering Acceleron Pharma (NASDAQ:XLRN), 11 have Buy rating, 1 Sell and 4 Hold. Therefore 69% are positive. Acceleron Pharma had 35 analyst reports since August 13, 2015 according to SRatingsIntel. The company was maintained on Friday, January 15 by FBR Capital. Citigroup upgraded Acceleron Pharma Inc. (NASDAQ:XLRN) on Thursday, March 2 to “Buy” rating. The company was initiated on Friday, November 20 by Oppenheimer. Credit Suisse downgraded it to “Hold” rating and $35.0 target in Thursday, September 21 report. As per Friday, June 23, the company rating was maintained by Oppenheimer. As per Wednesday, September 20, the company rating was maintained by Barclays Capital. RBC Capital Markets maintained the stock with “Hold” rating in Thursday, November 2 report. The rating was initiated by Citigroup on Thursday, September 29 with “Neutral”. The firm earned “Buy” rating on Monday, January 8 by H.C. Wainwright. The firm earned “Overweight” rating on Wednesday, April 27 by Barclays Capital.

Investors sentiment increased to 1.81 in 2017 Q3. Its up 0.37, from 1.44 in 2017Q2. It improved, as 12 investors sold XLRN shares while 30 reduced holdings. 30 funds opened positions while 46 raised stakes. 37.73 million shares or 12.48% more from 33.54 million shares in 2017Q2 were reported. Fmr Ltd Liability invested in 3.73M shares. Lord Abbett Ltd Llc reported 83,104 shares or 0.01% of all its holdings. Eam Investors Llc accumulated 56,427 shares. Nj State Employees Deferred Compensation Plan invested in 7,000 shares. Pictet Asset Management Limited accumulated 0.07% or 629,807 shares. Perceptive Limited Liability Corp, New York-based fund reported 1.62 million shares. California Pub Employees Retirement Sys reported 20,900 shares. Moreover, Great West Life Assurance Can has 0% invested in Acceleron Pharma Inc. (NASDAQ:XLRN). Hamilton Lane Advsrs Limited Liability Co owns 74,990 shares. Loring Wolcott & Coolidge Fiduciary Advsr Llp Ma accumulated 0% or 337 shares. Guggenheim Capital Lc owns 65,051 shares. Sg Americas invested in 12,239 shares. 109,346 were reported by State Common Retirement Fund. Evercore Wealth Ltd Liability Co owns 32,742 shares. Millennium Mngmt Ltd Liability invested in 359,304 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: